You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
SBIR TOPIC 294 PHASE I- DEVELOPMENT OF GLYCOSYLATION- SPECIFIC RESEARCH
SBC: NECTAGEN INC Topic: NCIThe function of many cancer related proteins is modulated by modifications such as phosphorylation and glycosylation. The development of antibodies that recognize site-specific phosphorylation has vastly improved our understanding of signal transductionand cancer cell physiology and regulation. However, almost no available antibodies recognize site specific glycosylation, and in particular, N-a ...
SBIR Phase I 2011 Department of Health and Human ServicesNational Institutes of Health -
TAS:: 75 0896::TAS SBIR PHASE I TOPIC NCCAM 002
SBC: APHIOS CORPORATION Topic: NCIThis Phase I, SBIR contract is to conduct a thorough biological and phytochemical analysis of Harpagophytum procumbens. This should result in discovery of new biologically active molecules and/or a more comprehensive understanding of the contributions madeby the known constituents.
SBIR Phase I 2011 Department of Health and Human ServicesNational Institutes of Health -
TAS::75 0849::TAS SBIR TOPIC 307 PHASE I NOVEL IMAGING AGENTS TO EXPAND THE CLINICAL TOOLKIT FOR CANCER DIAGNOSIS, STAGING, AND TREATMENT
SBC: iTi Health Topic: NCIPhase I - Topic 307 The long term objective of this work is to transform the clinical practice of diagnosing and treating pancreatic cancer through the development of a targeted imaging reagent. The 5-year survival rate for patients diagnosed with pancreatic cancer is less than 5%. Those with respectable disease have a much greater likelihood of survival, however 80% of patients are diagnosed wit ...
SBIR Phase I 2011 Department of Health and Human ServicesNational Institutes of Health -
TAS::75 0849::TAS SBIR TOPIC 307 PHASE I NOVEL IMAGING AGENTS TO EXPAND THE CLINICAL TOOLKIT FOR CANCER DIAGNOSIS, STAGING, AND TREATMENT
SBC: LUMICELL INC Topic: NCIPhase I - Topic 307 Lumicell's technology is an intraoperative imaging agent used in conjuction iwht our novel hand-held detector. Together they detect single residual cancer cells in the tumor bed, which guide the surgeon to complete removal of cancer. The aims of this project are to extend the characterization of the technology from sarcoma to breast cancer (mouse model) and to develop and ...
SBIR Phase I 2011 Department of Health and Human ServicesNational Institutes of Health -
TAS::75 0893::TAS RAPID LARGE SCALE PRODUCTION OF PROTEIN THERAPEUTICS
SBC: ANTAGEN BIOSCIENCES INC Topic: NIDAAWith a long-term objective to efficiently manufacture protein therapeutics, the Contractor developed a mammalian expression vector pATG that incorporates human DNA regulatory elements to render long-term cell line stability, ensures the most stringent selection of high producers, and uses the strongest signal sequence for high level secretory expression without gene amplification. This system sho ...
SBIR Phase I 2011 Department of Health and Human ServicesNational Institutes of Health -
RandD-OTHER R and D-B RES
SBC: AGILTRON, INC. Topic: NIEHSAgiltron proposes to develop volumetric optical coherence microscopic imaging technology for the full anterior chamber of the rabbit eye with high depth resolution, high speed, and high sensitivity to quantitatively assess the depth and extent of initial injury (001) in ocular irritant test. Studies pioneered by Dr. Jester have provided strong evidence that 001 is an objective and universal biomar ...
SBIR Phase I 2011 Department of Health and Human ServicesNational Institutes of Health -
SBIR PHASE 1 TOPIC 43
SBC: APHIOS CORPORATION Topic: NHLBIThe contractor will identify methodologies for broad spectrum inactivation of pathogens in red blood cell concentrates(RBCC). RBCCs are the main components of blood used in transfusion medicine, yet currently there are no FDAapproved methods for broad spectrum pathogen inactivation for RBCCs; instead, the risk of transfusion associatedpathogen transmission is reduced by screening the transfused bl ...
SBIR Phase I 2011 Department of Health and Human ServicesNational Institutes of Health -
TAS::75 0894::TAS SBIR FAST-TRACK (TOPIC 37)- PHASE II OPTION EXERCISED
SBC: Pinnacle Technology, Inc. Topic: NICHDUnder Phase I of this SBIR Fast-track project, a base manufacturing process to produce a reliable, robust ethanol biosensor will be developed and the feasibility of the biosensor, capable of real-time monitoring of ethanol, will be demonstrated and a functional prototype ethanol biosensor will be delivered. During Phase II, the biosensor design prototype and multi-sensor array (a three-channel ...
SBIR Phase I 2011 Department of Health and Human ServicesNational Institutes of Health -
BIOMEDICAL (APPLIED/EXPLORATORY)
SBC: Environmental Metrology Corporation Topic: NHLBIThe purpose of the Phase I contract is to support Net eSolutions Corporation (NETE) in development of the software that assists in exploring multidimensional textual data, understanding complex concepts, and portfolio analysis. The tool will be useful to scientists, general public, program and public health officials, and policy makers.
SBIR Phase I 2011 Department of Health and Human ServicesNational Institutes of Health -
Multi-Enzyme Based Sensor for Water Contaminant Detection
SBC: LUNA INNOVATIONS INCORPORATED Topic: A10AT025Luna Innovations collaborating with the University of New Mexico will determine the feasibility of developing a light weight handheld multi-enzyme sensor device that is capable of detecting a wide array of water contaminants, toxic industrial chemicals (TICs). The proposed multi-enzyme electrode technology will provide significant improvements in sensitivity, operational stability, and shelf li ...
STTR Phase I 2011 Department of DefenseArmy